应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
RVMD Revolution Medicines, Inc.
休市中 10-18 16:00:00 EDT
50.43
+0.43
+0.86%
盘后
50.43
+0.00
0.00%
16:05 EDT
最高
50.94
最低
49.86
成交量
64.93万
今开
50.10
昨收
50.00
日振幅
2.16%
总市值
84.24亿
流通市值
77.48亿
总股本
1.67亿
成交额
3,279万
换手率
0.42%
流通股本
1.54亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 股价大跌23.67%报0.109美元
市场透视 · 10-17 21:37
Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 股价大跌23.67%报0.109美元
Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 早盘大幅上涨5.60%
市场透视 · 10-16 21:31
Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 早盘大幅上涨5.60%
Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 早盘快速跳水33.33%报0.080美元
市场透视 · 10-14
Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 早盘快速跳水33.33%报0.080美元
Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)股价重挫13.14% 市值跌1489.67万美元
市场透视 · 10-11
Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)股价重挫13.14% 市值跌1489.67万美元
Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 早盘急速上涨18.13%报0.120美元
市场透视 · 10-09
Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 早盘急速上涨18.13%报0.120美元
Revolution Medicines, Inc.盘中异动 股价大涨5.03%报49.72美元
市场透视 · 10-09
Revolution Medicines, Inc.盘中异动 股价大涨5.03%报49.72美元
Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)股价重挫16.09% 市值跌3648.2万美元
市场透视 · 10-07
Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)股价重挫16.09% 市值跌3648.2万美元
Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 股价大涨5.05%报0.210美元
市场透视 · 10-04
Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 股价大涨5.05%报0.210美元
Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 股价大跌5.00%报0.190美元
市场透视 · 10-02
Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 股价大跌5.00%报0.190美元
Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 临近收盘股价大涨9.85%报0.148美元
市场透视 · 10-01
Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 临近收盘股价大涨9.85%报0.148美元
Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 快速下跌9.21%报0.135美元
市场透视 · 09-26
Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 快速下跌9.21%报0.135美元
Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 早盘股价大跌50.58%报0.060美元
市场透视 · 09-24
Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 早盘股价大跌50.58%报0.060美元
Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)股价上涨35.00% 市值涨6695.85万美元
市场透视 · 09-23
Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)股价上涨35.00% 市值涨6695.85万美元
Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 快速下跌7.64%
市场透视 · 09-20
Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 快速下跌7.64%
Revolution Medicines, Inc.盘中异动 早盘快速拉升5.02%报46.27美元
市场透视 · 09-19
Revolution Medicines, Inc.盘中异动 早盘快速拉升5.02%报46.27美元
Revolution Medicines, Inc.2024财年第二财季实现净利润-1.33亿美元,同比减少35.30%
自选股智能写手 · 08-17
Revolution Medicines, Inc.2024财年第二财季实现净利润-1.33亿美元,同比减少35.30%
Revolution Medicines Inc 预计每股亏损 77 美分 - 财报前瞻
Reuters · 08-06
Revolution Medicines Inc 预计每股亏损 77 美分 - 财报前瞻
Revolution Medicines, Inc.盘中异动 早盘股价大跌6.18%
自选股智能写手 · 08-05
Revolution Medicines, Inc.盘中异动 早盘股价大跌6.18%
巴克莱:维持Revolution Medicines(RVMD.US)评级,由增持调整至增持评级, 目标价由52.00美元调整至54.
智通财经 · 07-18
巴克莱:维持Revolution Medicines(RVMD.US)评级,由增持调整至增持评级, 目标价由52.00美元调整至54.
HC Wainwright & Co.:维持Revolution Medicines(RVMD.US)评级,由买入调整至买入评级, 目标价由44.
智通财经 · 07-16
HC Wainwright & Co.:维持Revolution Medicines(RVMD.US)评级,由买入调整至买入评级, 目标价由44.
公司概况
公司名称:
Revolution Medicines, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Revolution Medicines, Inc.成立于2014年10月,是特拉华州的一家公司。该公司是一家临床阶段的精准肿瘤学公司,专注于开发靶向疗法,以抑制RAS成瘾癌症的前沿靶点。该公司拥有先进的基于结构的药物发现能力,其基础是深厚的化学生物学和癌症药理学知识以及创新的专有技术,能够创造适合非常规结合位点的小分子。该公司对癌症的遗传驱动因素和适应性耐药机制的了解,加上强大的药物发现和药物化学能力,指导建立了一个针对RAS通路和相关通路中的关键信号节点的深层管道。
发行价格:
--
{"stockData":{"symbol":"RVMD","market":"US","secType":"STK","nameCN":"Revolution Medicines, Inc.","latestPrice":50.43,"timestamp":1729281600000,"preClose":50,"halted":0,"volume":649297,"hourTrading":{"tag":"盘后","latestPrice":50.43,"preClose":50.43,"latestTime":"16:05 EDT","volume":33000,"amount":1664187.72,"timestamp":1729281938290},"delay":0,"floatShares":153647397,"shares":167038943,"eps":-3.579193,"marketStatus":"休市中","marketStatusCode":7,"change":0.43,"latestTime":"10-18 16:00:00 EDT","open":50.1,"high":50.94,"low":49.86,"amount":32790437.383462,"amplitude":0.0216,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.579193,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1729497600000},"adr":0,"listingDate":1581570000000,"adjPreClose":50,"preHourTrading":{"tag":"盘前","latestPrice":50.11,"preClose":50,"latestTime":"09:29 EDT","volume":4357,"amount":217669.1845,"timestamp":1729258144106},"postHourTrading":{"tag":"盘后","latestPrice":50.43,"preClose":50.43,"latestTime":"16:05 EDT","volume":33000,"amount":1664187.72,"timestamp":1729281938290},"volumeRatio":0.655369390725007,"impliedVol":0.9294,"impliedVolPercentile":0.9365},"requestUrl":"/m/hq/s/RVMD/wiki","defaultTab":"wiki","newsList":[{"id":"2476207481","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 股价大跌23.67%报0.109美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476207481","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476207481?lang=zh_cn&edition=full","pubTime":"2024-10-17 21:37","pubTimestamp":1729172222,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日21时37分,Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动,股价快速下跌23.67%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中,整体涨幅为0.27%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介:Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司,致力于开发新颖的靶向疗法,以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标,尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410172137029f4a8826&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410172137029f4a8826&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD","BK4139","RVMDW"],"gpt_icon":0},{"id":"2475099222","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 早盘大幅上涨5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475099222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475099222?lang=zh_cn&edition=full","pubTime":"2024-10-16 21:31","pubTimestamp":1729085463,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日21时31分,Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动,股价急速上涨5.60%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中,整体跌幅为0.34%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介:Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司,致力于开发新颖的靶向疗法,以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标,尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101621310398e3cc20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101621310398e3cc20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RVMDW","RVMD"],"gpt_icon":0},{"id":"2475362951","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 早盘快速跳水33.33%报0.080美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475362951","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475362951?lang=zh_cn&edition=full","pubTime":"2024-10-14 21:31","pubTimestamp":1728912703,"startTime":"0","endTime":"0","summary":"北京时间2024年10月14日21时31分,Revolution Medicines Inc C/Wts 17/12/2026 股票出现波动,股价快速跳水33.33%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中,整体涨幅为0.08%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介:Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司,致力于开发新颖的靶向疗法,以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标,尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101421314495a748dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101421314495a748dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD","BK4139","RVMDW"],"gpt_icon":0},{"id":"2474818092","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)股价重挫13.14% 市值跌1489.67万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474818092","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474818092?lang=zh_cn&edition=full","pubTime":"2024-10-11 21:46","pubTimestamp":1728654367,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日21时46分,Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动,股价急速下跌13.14%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中,整体涨幅为0.38%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介:Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司,致力于开发新颖的靶向疗法,以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标,尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101121460895a07ae5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101121460895a07ae5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMDW","RVMD","BK4139"],"gpt_icon":0},{"id":"2474224784","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 早盘急速上涨18.13%报0.120美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474224784","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474224784?lang=zh_cn&edition=full","pubTime":"2024-10-09 22:30","pubTimestamp":1728484202,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日22时30分,Revolution Medicines Inc C/Wts 17/12/2026 股票出现波动,股价急速拉升18.13%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中,整体跌幅为0.43%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介:Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司,致力于开发新颖的靶向疗法,以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标,尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009223002959b11c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009223002959b11c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMDW","RVMD","BK4139"],"gpt_icon":0},{"id":"2474940063","title":"Revolution Medicines, Inc.盘中异动 股价大涨5.03%报49.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474940063","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474940063?lang=zh_cn&edition=full","pubTime":"2024-10-09 03:12","pubTimestamp":1728414752,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日03时12分,Revolution Medicines, Inc.股票出现波动,股价急速上涨5.03%。截至发稿,该股报49.72美元/股,成交量102.686万股,换手率0.61%,振幅5.64%。Revolution Medicines, Inc.股票所在的生物技术行业中,整体涨幅为0.42%。Revolution Medicines, Inc.公司简介:Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司,致力于开发新颖的靶向疗法,以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标,尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410090312339719f07c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410090312339719f07c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD","BK4139"],"gpt_icon":0},{"id":"2473110360","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)股价重挫16.09% 市值跌3648.2万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473110360","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473110360?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:31","pubTimestamp":1728307866,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时31分,Revolution Medicines Inc C/Wts 17/12/2026 股票出现波动,股价快速下挫16.09%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中,整体涨幅为0.20%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介:Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司,致力于开发新颖的靶向疗法,以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标,尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410072131069595c164&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410072131069595c164&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD","BK4139","RVMDW"],"gpt_icon":0},{"id":"2472640304","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 股价大涨5.05%报0.210美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472640304","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472640304?lang=zh_cn&edition=full","pubTime":"2024-10-04 02:51","pubTimestamp":1727981460,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日02时51分,Revolution Medicines Inc C/Wts 17/12/2026 股票出现波动,股价急速拉升5.05%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中,整体跌幅为1.68%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介:Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司,致力于开发新颖的靶向疗法,以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标,尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410040251009f278aaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410040251009f278aaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMDW","BK4139","RVMD"],"gpt_icon":0},{"id":"2472250405","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 股价大跌5.00%报0.190美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472250405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472250405?lang=zh_cn&edition=full","pubTime":"2024-10-02 21:32","pubTimestamp":1727875938,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日21时32分,Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动,股价快速下挫5.00%。截至发稿,该股报0.190美元/股,成交量100股,换手率0.00%,振幅0.00%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中,整体跌幅为1.01%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介:Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司,致力于开发新颖的靶向疗法,以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标,尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241002213218958bd625&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241002213218958bd625&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD","RVMDW","BK4139"],"gpt_icon":0},{"id":"2472356091","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 临近收盘股价大涨9.85%报0.148美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472356091","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472356091?lang=zh_cn&edition=full","pubTime":"2024-10-01 04:00","pubTimestamp":1727726405,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日04时00分,Revolution Medicines Inc C/Wts 17/12/2026 股票出现波动,股价大幅拉升9.85%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中,整体跌幅为0.16%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介:Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司,致力于开发新颖的靶向疗法,以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标,尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100104000598e39ea2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100104000598e39ea2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMDW","RVMD","BK4139"],"gpt_icon":0},{"id":"2470753883","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 快速下跌9.21%报0.135美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470753883","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470753883?lang=zh_cn&edition=full","pubTime":"2024-09-26 22:53","pubTimestamp":1727362384,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日22时53分,Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动,股价大幅下跌9.21%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中,整体涨幅为0.34%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介:Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司,致力于开发新颖的靶向疗法,以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标,尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409262253049719cdab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409262253049719cdab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMDW","BK4139","RVMD"],"gpt_icon":0},{"id":"2470090284","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 早盘股价大跌50.58%报0.060美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470090284","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470090284?lang=zh_cn&edition=full","pubTime":"2024-09-24 22:15","pubTimestamp":1727187301,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日22时15分,Revolution Medicines Inc C/Wts 17/12/2026 股票出现波动,股价大幅下挫50.58%。截至发稿,该股报0.060美元/股,成交量2股,换手率0.00%,振幅0.00%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中,整体跌幅为0.79%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介:Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司,致力于开发新颖的靶向疗法,以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标,尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924221501957a6eaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924221501957a6eaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RVMD","RVMDW"],"gpt_icon":0},{"id":"2469614144","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)股价上涨35.00% 市值涨6695.85万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469614144","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469614144?lang=zh_cn&edition=full","pubTime":"2024-09-23 23:56","pubTimestamp":1727106961,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日23时56分,Revolution Medicines Inc C/Wts 17/12/2026 股票出现波动,股价急速上涨35.00%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中,整体跌幅为0.24%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介:Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司,致力于开发新颖的靶向疗法,以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标,尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409232356019577fc38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409232356019577fc38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD","BK4139","RVMDW"],"gpt_icon":0},{"id":"2468197500","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 快速下跌7.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468197500","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468197500?lang=zh_cn&edition=full","pubTime":"2024-09-20 00:34","pubTimestamp":1726763665,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日00时34分,Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动,股价快速下跌7.64%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中,整体涨幅为1.69%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介:Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司,致力于开发新颖的靶向疗法,以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标,尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920003425a1db37ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920003425a1db37ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD","BK4139","RVMDW"],"gpt_icon":0},{"id":"2468508150","title":"Revolution Medicines, Inc.盘中异动 早盘快速拉升5.02%报46.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468508150","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468508150?lang=zh_cn&edition=full","pubTime":"2024-09-19 22:13","pubTimestamp":1726755199,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日22时13分,Revolution Medicines, Inc.股票出现波动,股价快速拉升5.02%。Revolution Medicines, Inc.股票所在的生物技术行业中,整体涨幅为1.23%。Revolution Medicines, Inc.公司简介:Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司,致力于开发新颖的靶向疗法,以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标,尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919221320ab64a48f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919221320ab64a48f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RVMD"],"gpt_icon":0},{"id":"2460324916","title":"Revolution Medicines, Inc.2024财年第二财季实现净利润-1.33亿美元,同比减少35.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460324916","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460324916?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824031,"startTime":"0","endTime":"0","summary":"8月17日,Revolution Medicines, Inc.公布财报,公告显示公司2024财年第二财季净利润为-1.33亿美元,同比减少35.30%;其中营业收入为0.00美元,每股基本收益为-0.81美元。从资产负债表来看,Revolution Medicines, Inc.总负债1.90亿美元,其中短期债务8.33百万美元,资产负债比为9.52,流动比率为15.48。机构评级:截至2024年8月17日,当前有14家机构对Revolution Medicines, Inc.目标价做出预测,其中目标均价为59.29美元,其中最低目标价为54.00美元,最高目标价为73.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170004599f31b000&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170004599f31b000&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD"],"gpt_icon":0},{"id":"2457058818","title":"Revolution Medicines Inc 预计每股亏损 77 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457058818","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457058818?lang=zh_cn&edition=full","pubTime":"2024-08-06 10:03","pubTimestamp":1722909825,"startTime":"0","endTime":"0","summary":" * Revolution Medicines Inc 将于8月7日公布截至2024年6月30日的财报,预计该公司的季度收入将出现下降。* 根据LSEG的数据,14位分析师的平均预期显示,这家总部位于加利福尼亚州红木城的公司的营收将从去年同期的382万美元下降80.4%,至75万美元。* LSEG 分析师对 Revolution Medicines Inc 的平均预期是每股亏损 77 美分。* 华尔街对Revolution Medicines Inc的12个月目标价中位数为57.00美元,高于其最新收盘价42.48美元。8月6日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Revolution Medicines Inc 预计每股亏损 77 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD"],"gpt_icon":0},{"id":"2457877308","title":"Revolution Medicines, Inc.盘中异动 早盘股价大跌6.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457877308","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457877308?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:41","pubTimestamp":1722865317,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时41分,Revolution Medicines, Inc.股票出现异动,股价快速下跌6.18%。Revolution Medicines, Inc.股票所在的生物技术行业中,整体跌幅为2.33%。Revolution Medicines, Inc.公司简介:Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司,致力于开发新颖的靶向疗法,以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标,尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052141579f10759b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052141579f10759b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RVMD"],"gpt_icon":0},{"id":"2452534436","title":"巴克莱:维持Revolution Medicines(RVMD.US)评级,由增持调整至增持评级, 目标价由52.00美元调整至54.","url":"https://stock-news.laohu8.com/highlight/detail?id=2452534436","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452534436?lang=zh_cn&edition=full","pubTime":"2024-07-18 23:38","pubTimestamp":1721317111,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RVMD","BK4139"],"gpt_icon":0},{"id":"2451930059","title":"HC Wainwright & Co.:维持Revolution Medicines(RVMD.US)评级,由买入调整至买入评级, 目标价由44.","url":"https://stock-news.laohu8.com/highlight/detail?id=2451930059","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451930059?lang=zh_cn&edition=full","pubTime":"2024-07-16 19:49","pubTimestamp":1721130564,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","RVMD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.revmed.com","stockEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":0.1446},{"period":"3month","weight":0.093},{"period":"6month","weight":0.4442},{"period":"1year","weight":0.739},{"period":"ytd","weight":0.7584}],"compareEarnings":[{"period":"1week","weight":0.0086},{"period":"1month","weight":0.0413},{"period":"3month","weight":0.0648},{"period":"6month","weight":0.1806},{"period":"1year","weight":0.3709},{"period":"ytd","weight":0.2299}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Revolution Medicines, Inc.成立于2014年10月,是特拉华州的一家公司。该公司是一家临床阶段的精准肿瘤学公司,专注于开发靶向疗法,以抑制RAS成瘾癌症的前沿靶点。该公司拥有先进的基于结构的药物发现能力,其基础是深厚的化学生物学和癌症药理学知识以及创新的专有技术,能够创造适合非常规结合位点的小分子。该公司对癌症的遗传驱动因素和适应性耐药机制的了解,加上强大的药物发现和药物化学能力,指导建立了一个针对RAS通路和相关通路中的关键信号节点的深层管道。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.002389},{"month":2,"riseRate":0.75,"avgChangeRate":0.00657},{"month":3,"riseRate":0.6,"avgChangeRate":-0.008788},{"month":4,"riseRate":0.6,"avgChangeRate":0.034923},{"month":5,"riseRate":0.4,"avgChangeRate":-0.035334},{"month":6,"riseRate":1,"avgChangeRate":0.06444},{"month":7,"riseRate":0.4,"avgChangeRate":-0.00346},{"month":8,"riseRate":0.6,"avgChangeRate":0.068181},{"month":9,"riseRate":0.4,"avgChangeRate":-0.000203},{"month":10,"riseRate":0.6,"avgChangeRate":-0.041592},{"month":11,"riseRate":0.75,"avgChangeRate":0.181921},{"month":12,"riseRate":0.5,"avgChangeRate":0.014112}],"exchange":"NASDAQ","name":"Revolution Medicines, Inc.","nameEN":"Revolution Medicines, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.0","shortVersion":"4.29.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Revolution Medicines, Inc.(RVMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Revolution Medicines, Inc.(RVMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Revolution Medicines, Inc.,RVMD,Revolution Medicines, Inc.股票,Revolution Medicines, Inc.股票老虎,Revolution Medicines, Inc.股票老虎国际,Revolution Medicines, Inc.行情,Revolution Medicines, Inc.股票行情,Revolution Medicines, Inc.股价,Revolution Medicines, Inc.股市,Revolution Medicines, Inc.股票价格,Revolution Medicines, Inc.股票交易,Revolution Medicines, Inc.股票购买,Revolution Medicines, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Revolution Medicines, Inc.(RVMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Revolution Medicines, Inc.(RVMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}